Sentiss
India - GurugramBiotechnology
Focus: Sentiss is a publicly listed Indian biotech company founded in 2003, specializing in ophthalmic, respiratory, otolaryngologic, and wound care products. The company operates primarily in generics and branded generics across focused therapeutic areas.
Profile data last refreshed 8h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Sentiss
AI assessmentNot HiringNo open roles listed right now. Follow Sentiss to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Sentiss's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
Post-LOE
Combination carbonic anhydrase inhibitor + beta-blocker; mature ophthalmic franchise product now off-patent.
Help build intelligence for Sentiss
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.